Clinical trial Recruiting at 1 site Interventional

One-Page Truth-Telling Aid to Guide Cancer Discussions

Official title: A One-Page Truth-Telling Aid for Cancer Disclosure in Taiwan: A Two-Arm Pragmatic Randomized Controlled Trial

Run by Chang Gung University · NCT07730164 · Data updated 2026-11-12

A one-page tool is tested to help doctors quickly understand a cancer patient’s information preferences before a consultation.

Quick facts

Study typeInterventional
SexAll
Enrollment400 (estimated)
SponsorChang Gung University
Academic / other
Locations1 site (Taoyuan)
StatusRecruiting
StartedNovember 27, 2025
Main results expectedApril 2027
Study endsJuly 2027
Registry record updatedJuly 28, 2026
Trial IDNCT07730164 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Physicians who treat cancer patients in participating outpatient departments and their eligible Mandarin-speaking cancer patients who can complete questionnaires with or without assistance.

Probably not a fit

Patients whose physicians do not adopt the aid or who prefer not to share preferences may see little to no change in communication outcomes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pragmatic, two-arm study compares the use of a One-Page Truth-Telling Aid versus a blank question sheet in cancer-related consultations. Physicians in the experimental arm receive the aid to better tailor disclosures to patient preferences, while patients in the control arm use a blank sheet to list questions. The trial looks at patient satisfaction with information, emotional distress after the visit, and physicians’ confidence in communicating about cancer. It is conducted in outpatient oncology settings with Mandarin-speaking participants and involves physician-patient dyads assigned by physician group. The study is designed to assess whether pre-visit alignment on disclosure preferences can improve communication and outcomes in routine care.

Why it matters

Potential benefit: If successful, patients may experience clearer explanations, reduced distress, and a smoother, more person-centered disclosure process.

How similar studies have gone: Prior work suggests structured communication aids can influence satisfaction and perceived clarity, but this exact one-page tool in truth-telling is novel for this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
【Physicians】

* Inclusion Criteria:

  * Physicians who provide clinical care for patients with cancer in participating outpatient departments.
  * Physicians who are involved in cancer-related truth-telling or disclosure consultations.
  * Physicians who are willing to participate and provide informed consent.
* Exclusion Criteria:

  * Physicians who are unable or unwilling to complete study procedures or follow-up assessments.

【Patients】

* Inclusion Criteria:

  * Patients diagnosed with cancer.
  * Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status.
  * Patients who are able to communicate in Mandarin Chinese or Taiwanese.
  * Patients who are able to complete questionnaires independently or with assistance from the research assistant.
  * Patients who are willing to participate and provide informed consent.
* Exclusion Criteria:

  * Patients who are unable to provide informed consent.
  * Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff.
  * Patients who are unable to complete the study questionnaires even with assistance.

Where it's running

  • Chang Gung University
    Taoyuan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.